Home Merck dives into 'superbug' chase with Cubist
 

Keywords :   


Merck dives into 'superbug' chase with Cubist

2014-12-08 17:23:28| Biotech - Topix.net

Merck will spend $8.4 billion to buy Cubist Pharmaceuticals and push deeper into treating so-called "superbugs" that have drawn dire warnings from global health organizations. The company said Monday that the deal will give it stronger footing in hospital acute care and help it address antibiotic resistance, which the Whitehouse Station, New Jersey, drugmaker called a critical area of unmet medical need.

Tags: chase merck dives cubist

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11 HUNTER × HUNTER 135
14.11 2023 25.5cm
14.112014
14.11FIREWING PEGASUS
14.11 2024
14.11 1-15
14.11 90s AXO SPORTS BMX motocross
14.11
More »